Andrew R. Allen - 11 Jun 2021 Form 4 Insider Report for Epizyme, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 11 Jun 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Jun 2021, 16:37:03 UTC
Prior SEC filing: 09 Jun 2021
Next SEC filing: 10 Dec 2021
Source filing: View source filing
Reporting owner signature: /s/ John Weidenbruch, attorney-in-fact

Key filing fact

Andrew R. Allen filed Form 4 for Epizyme, Inc. on 15 Jun 2021.

Key facts

This page summarizes Andrew R. Allen's Form 4 filing for Epizyme, Inc..
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 15 Jun 2021, 16:37.

Change

Previous filing in this sequence was filed on 09 Jun 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EPZM transaction

Common Stock, par value $0.0001

Award

Transaction value: $0
Shares: +8,060
Change %: +64%
Price: $0.000000
Shares after: 20,560
Date: 11 Jun 2021
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EPZM transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +40,559
Change %
Price: $0.000000
Shares after: 40,559
Date: 11 Jun 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 40,559
Exercise price: $8.53
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Consists of shares of Common Stock issuable under 8,060 restricted stock units ("RSUs") granted on June 11, 2021, which RSUs are scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service as a director. Each RSU represents the right to receive one share of Common Stock upon vesting. In the event of a change in control of the Issuer, the RSUs will vest in full.

Footnote F2

This option was granted on June 11, 2021 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service as a director. In the event of a change in control of the Issuer, the option will become exercisable in full.